StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) KPIs and segments

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Addex Therapeutics's business

Coming soon

This tab will track the numbers specific to Addex Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?